1 | biomarkers | 6,124 |
2 | foci | 489 |
3 | substitutes | 355 |
4 | surrogates | 296 |
5 | proxies | 92 |
6 | endophenotypes | 42 |
7 | biocatalysts | 37 |
8 | risk-factors | 36 |
9 | sentinels | 29 |
10 | esterases | 26 |
11 | radioligands | 22 |
12 | localisations | 14 |
13 | inoculants | 13 |
14 | radioprotectors | 13 |
15 | preventives | 12 |
16 | allies | 11 |
17 | neuroprotectants | 10 |
18 | parameterizations | 9 |
19 | glycosidases | 8 |
20 | bio-markers | 6 |
21 | biomarkers/panels | 6 |
22 | coprescriptions | 6 |
23 | h-aggregates | 6 |
24 | imepitoin | 6 |
25 | immunoreactions | 6 |
26 | β-d-glucans | 6 |
27 | ferritins | 5 |
28 | indolamine | 4 |
29 | musts | 4 |
30 | one-by-one | 4 |
31 | tastant | 4 |
32 | time-to-efficacy-failure | 4 |
33 | bio-inspired | 3 |
34 | biomaterials/biologicals | 3 |
35 | cns-effects | 3 |
36 | nosography | 3 |
37 | addenda | 2 |
38 | cocarcinogens | 2 |
39 | dipyrazolo-fused | 2 |
40 | n-benzoyltransferase | 2 |
41 | neuroglia | 2 |
42 | oxoferin | 2 |
43 | panaceas | 2 |
44 | resolvent | 2 |
45 | s-stereoisomers | 2 |
46 | self-ambivalence | 2 |
47 | 1,3,2,4,5-dioxazadisil- | 1 |
48 | 4-alkoxy- | 1 |
49 | 7-nitroquinoxalin-2-ones | 1 |
50 | anti-cox-1 | 1 |
51 | anti-resonant | 1 |
52 | arthridites | 1 |
53 | bio-mark | 1 |
54 | chemoimmunotherapeutics | 1 |
55 | cis/trans-4- | 1 |
56 | data-which | 1 |
57 | dihydro-1,3-oxazinoporphyrins | 1 |
58 | dual-pam-100 | 1 |
59 | filaricides | 1 |
60 | ischemia-time-insensitive | 1 |
61 | kttks | 1 |
62 | mechanisms-indices | 1 |
63 | metallodrug | 1 |
64 | non-morphinan | 1 |
65 | organogelators | 1 |
66 | pancratistatin | 1 |
67 | uv-a/b | 1 |
68 | value/negative | 1 |
1 | 1,3,2,4,5-dioxazadisil- | 1 |
2 | 4-alkoxy- | 1 |
3 | 7-nitroquinoxalin-2-ones | 1 |
4 | addenda | 2 |
5 | allies | 11 |
6 | anti-cox-1 | 1 |
7 | anti-resonant | 1 |
8 | arthridites | 1 |
9 | bio-inspired | 3 |
10 | bio-mark | 1 |
11 | bio-markers | 6 |
12 | biocatalysts | 37 |
13 | biomarkers | 6,124 |
14 | biomarkers/panels | 6 |
15 | biomaterials/biologicals | 3 |
16 | chemoimmunotherapeutics | 1 |
17 | cis/trans-4- | 1 |
18 | cns-effects | 3 |
19 | cocarcinogens | 2 |
20 | coprescriptions | 6 |
21 | data-which | 1 |
22 | dihydro-1,3-oxazinoporphyrins | 1 |
23 | dipyrazolo-fused | 2 |
24 | dual-pam-100 | 1 |
25 | endophenotypes | 42 |
26 | esterases | 26 |
27 | ferritins | 5 |
28 | filaricides | 1 |
29 | foci | 489 |
30 | glycosidases | 8 |
31 | h-aggregates | 6 |
32 | imepitoin | 6 |
33 | immunoreactions | 6 |
34 | indolamine | 4 |
35 | inoculants | 13 |
36 | ischemia-time-insensitive | 1 |
37 | kttks | 1 |
38 | localisations | 14 |
39 | mechanisms-indices | 1 |
40 | metallodrug | 1 |
41 | musts | 4 |
42 | n-benzoyltransferase | 2 |
43 | neuroglia | 2 |
44 | neuroprotectants | 10 |
45 | non-morphinan | 1 |
46 | nosography | 3 |
47 | one-by-one | 4 |
48 | organogelators | 1 |
49 | oxoferin | 2 |
50 | panaceas | 2 |
51 | pancratistatin | 1 |
52 | parameterizations | 9 |
53 | preventives | 12 |
54 | proxies | 92 |
55 | radioligands | 22 |
56 | radioprotectors | 13 |
57 | resolvent | 2 |
58 | risk-factors | 36 |
59 | s-stereoisomers | 2 |
60 | self-ambivalence | 2 |
61 | sentinels | 29 |
62 | substitutes | 355 |
63 | surrogates | 296 |
64 | tastant | 4 |
65 | time-to-efficacy-failure | 4 |
66 | uv-a/b | 1 |
67 | value/negative | 1 |
68 | β-d-glucans | 6 |
1 | cis/trans-4- | 1 |
2 | 1,3,2,4,5-dioxazadisil- | 1 |
3 | 4-alkoxy- | 1 |
4 | dual-pam-100 | 1 |
5 | anti-cox-1 | 1 |
6 | addenda | 2 |
7 | neuroglia | 2 |
8 | uv-a/b | 1 |
9 | bio-inspired | 3 |
10 | dipyrazolo-fused | 2 |
11 | self-ambivalence | 2 |
12 | indolamine | 4 |
13 | one-by-one | 4 |
14 | time-to-efficacy-failure | 4 |
15 | n-benzoyltransferase | 2 |
16 | value/negative | 1 |
17 | ischemia-time-insensitive | 1 |
18 | metallodrug | 1 |
19 | data-which | 1 |
20 | foci | 489 |
21 | bio-mark | 1 |
22 | non-morphinan | 1 |
23 | imepitoin | 6 |
24 | oxoferin | 2 |
25 | pancratistatin | 1 |
26 | panaceas | 2 |
27 | chemoimmunotherapeutics | 1 |
28 | radioligands | 22 |
29 | mechanisms-indices | 1 |
30 | filaricides | 1 |
31 | allies | 11 |
32 | proxies | 92 |
33 | 7-nitroquinoxalin-2-ones | 1 |
34 | endophenotypes | 42 |
35 | glycosidases | 8 |
36 | esterases | 26 |
37 | h-aggregates | 6 |
38 | surrogates | 296 |
39 | arthridites | 1 |
40 | substitutes | 355 |
41 | preventives | 12 |
42 | kttks | 1 |
43 | biomaterials/biologicals | 3 |
44 | biomarkers/panels | 6 |
45 | sentinels | 29 |
46 | β-d-glucans | 6 |
47 | cocarcinogens | 2 |
48 | dihydro-1,3-oxazinoporphyrins | 1 |
49 | ferritins | 5 |
50 | localisations | 14 |
51 | parameterizations | 9 |
52 | immunoreactions | 6 |
53 | coprescriptions | 6 |
54 | bio-markers | 6 |
55 | biomarkers | 6,124 |
56 | s-stereoisomers | 2 |
57 | organogelators | 1 |
58 | risk-factors | 36 |
59 | radioprotectors | 13 |
60 | cns-effects | 3 |
61 | inoculants | 13 |
62 | neuroprotectants | 10 |
63 | musts | 4 |
64 | biocatalysts | 37 |
65 | anti-resonant | 1 |
66 | tastant | 4 |
67 | resolvent | 2 |
68 | nosography | 3 |